GenCefe's mRNA synthesis platform integrates gene synthesis, plasmid preparation, in vitro transcription (IVT), purification, and quality control into a streamlined workflow for reliable mRNA production. Supported by in-house DNA template preparation and sequence optimization capabilities, the platform enables efficient project execution from construct design to final mRNA delivery. 

To support diverse research needs, GenCefe offers flexible options for capping strategies, Poly(A) tail designs, nucleotide modifications, purification levels, and production scales. In addition to custom mRNA synthesis, we provide a growing catalog of 100+ pre-designed mRNA products covering commonly used research targets, including reporter genes and other widely applied constructs. 

Platform Advantages:

· Integrated workflow from gene synthesis and plasmid preparation to IVT mRNA production

· Flexible customization of capping methods, Poly(A) tails, and nucleotide modifications

· 100+ catalog mRNA products supporting common research applications

· Standardized quality systems ensuring reliable performance and consistent results

GenCefe is committed to ensuring consistent product quality and strict data confidentiality throughout IVT mRNA synthesis projects. Standardized workflows covering DNA template preparation, in vitro transcription, purification, and analytical evaluation are implemented to ensure product consistency, reliability, and batch-to-batch reproducibility.

Quality Control

GenCefe applies a structured quality control system across the entire IVT mRNA production process. Standard QC is included in every project to ensure basic product quality and performance consistency, while additional application-oriented QC options are available for selection based on specific project requirements.

All products are manufactured under standardized workflows to ensure traceability, consistency, and reliable performance. Detailed QC specifications are available in corresponding product documentation, and Certificate of Analysis (CoA) is provided with every delivery.

Confidentiality

· Secure handling of all customer sequences and project-related information

· Restricted access to authorized personnel throughout the project lifecycle

· No disclosure of data to third parties without prior consent

· NDA agreements available upon request

GenCefe's IVT mRNA synthesis services are designed to simplify project execution while providing reliable, high-quality mRNA for research and development applications. By integrating DNA template preparation, IVT mRNA synthesis, purification, and quality control within a single workflow, GenCefe helps researchers reduce coordination complexity and accelerate project progress.

Value Highlights:

· One-stop support from gene synthesis and plasmid preparation to IVT mRNA production

· Flexible customization of mRNA sequence design, modifications, and production specifications

· Access to both custom mRNA synthesis services and a growing catalog of pre-designed mRNA products

· Standardized workflows and quality systems supporting consistent project outcomes

· Dedicated technical support throughout project planning, production, and delivery

GenCefe streamlines IVT mRNA ordering from project submission to final delivery. Customers can submit project requirements through an online inquiry form or by email, and our scientific team will work closely with you to define the optimal synthesis strategy and project specifications.

Ordering Process

1. Project Submission: Submit your sequence information and project requirements, including mRNA design, modifications, quantity, and intended application. 

2. Project Design & Order Confirmation: Our team reviews the project specifications, confirms the synthesis strategy, and finalizes the production plan and order details. 

3. Gene Synthesis & Plasmid Preparation: Leveraging GenCefe's in-house gene synthesis platform, DNA templates are prepared through gene synthesis and plasmid construction to support efficient and reliable IVT mRNA production. 

4. IVT mRNA Synthesis: mRNA is produced using optimized in vitro transcription workflows with optional modifications and purification strategies based on project requirements. 

5. Quality Control & Delivery: Finished products undergo quality evaluation according to project specifications and are delivered with supporting documentation for research use. 

Online Quote: [Submit Sequence Now]

Contact by email: [email protected]

GenCefe is committed to helping researchers move from concept to results through reliable biomolecule synthesis and integrated project support. With expertise spanning gene synthesis, plasmid preparation, IVT mRNA production, and quality management, we provide a streamlined experience that reduces project complexity and improves workflow efficiency.

Our one-stop platform enables seamless coordination across multiple project stages, helping customers save time, simplify supplier management, and maintain consistency throughout development and research activities.

Supported by standardized workflows, documented quality systems, and responsive technical support, GenCefe delivers dependable IVT mRNA solutions tailored to diverse research needs. Whether you require custom mRNA synthesis or commonly used catalog products, our team is committed to providing reliable products, transparent communication, and consistent project execution.

GenCefe's IVT mRNA synthesis services support a broad range of research and preclinical applications across vaccines, cell and gene therapies, immunotherapy, protein replacement, and genome editing. Flexible design options and customizable synthesis specifications enable researchers to accelerate development across diverse mRNA programs.

mRNA Vaccines

· Antigen-encoding mRNA for infectious disease vaccine research

· Cancer vaccine and neoantigen vaccine development

· Immunogenicity and vaccination studies

Cell Therapy & CAR-T Research

· mRNA-based CAR expression for cell engineering

· Transient expression of CARs, TCRs, and other therapeutic proteins

· Research supporting next-generation cell therapy development

Gene Editing

· Cas9, base editor, and other genome-editing mRNA constructs

· CRISPR-related research applications

· In vitro and in vivo gene editing studies

Protein Replacement & Therapeutic Research

· Expression of therapeutic proteins and functional biomolecules

· Research into protein replacement strategies

· Evaluation of mRNA-based therapeutic candidates

Immunotherapy & Functional Research

· Cytokine and immune-modulating protein expression

· Immune cell engineering studies

· Functional studies, target validation, and disease research

Research-scale projects start from 20 μg of IVT mRNA.

Customers can provide a DNA sequence, gene ID, plasmid information, or target protein details, as well as the required amount and modification. Our technical team can assist with project evaluation and design recommendations.

Yes. GenCefe provides an integrated workflow including gene synthesis, plasmid preparation, IVT mRNA synthesis, purification, and quality control.

Yes. Codon optimization can be performed based on the target expression system to support efficient protein expression.

Cap0 (m7GpppN), Cap1 (m7GpppNm), Cap2 (m7GpppNmNm), and uncapped mRNA options are available.

Yes. Multiple Poly(A) tail configurations are available, including fixed-length, continuous, linker-type, or no Poly(A) tail.

Common options include Pseudouridine (Ψ), N1-methylpseudouridine (m1Ψ), 5-Methoxy-UTP, N6-Methyladenosine, and unmodified mRNA.